John D Cramer1, Jonas T Johnson1, Marci L Nilsen2. 1. 1 Department of Otolaryngology-Head and Neck Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. 2. 2 Department of Acute and Tertiary Care, School of Nursing, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Abstract
OBJECTIVES: Pain is common among patients with cancer, stemming from both malignancy and side effects of treatment. The extent to which pain persists after treatment has received little attention. We examined the prevalence, predictors, and impact on quality of life (QOL) caused by pain among survivors of head and neck cancer. STUDY DESIGN: Cohort study. SETTING: Tertiary head and neck cancer survivorship clinic. SUBJECTS AND METHODS: We identified survivors of head and neck cancer ≥1 year after diagnosis and examined the prevalence and risk factors for development of pain. Pain and QOL were assessed with multiple QOL instruments. Ordinal regression modeling examined predictors of pain in survivors. RESULTS: We identified 175 patients at a median of 6.6 years after diagnosis. Among survivors, 45.1% reported pain, and 11.5% reported severe pain. Among patients with current pain, 46% reported low overall QOL versus only 12% of those without pain ( P < .001). On multivariable analysis after adjustment for age, sex, and stage of disease, pain was associated with trimodality treatment (odds ratio [OR], 3.55; 95% CI, 1.06-12.77). Multivariable analysis of QOL issues revealed that pain was associated with major depression (OR, 3.91; 95% CI, 1.68-9.11), anxiety (OR, 4.22; 95% CI, 2.28-7.81), poor recreation (OR, 3.31; 95% CI, 1.70-6.48), and low overall QOL (OR, 2.20; 95% CI, 1.12-4.34). CONCLUSIONS: Years after head and neck cancer treatment, pain remains a significant problem and is associated with worse QOL. Future efforts should focus on preventing pain from treatment and comprehensive management.
OBJECTIVES:Pain is common among patients with cancer, stemming from both malignancy and side effects of treatment. The extent to which pain persists after treatment has received little attention. We examined the prevalence, predictors, and impact on quality of life (QOL) caused by pain among survivors of head and neck cancer. STUDY DESIGN: Cohort study. SETTING: Tertiary head and neck cancer survivorship clinic. SUBJECTS AND METHODS: We identified survivors of head and neck cancer ≥1 year after diagnosis and examined the prevalence and risk factors for development of pain. Pain and QOL were assessed with multiple QOL instruments. Ordinal regression modeling examined predictors of pain in survivors. RESULTS: We identified 175 patients at a median of 6.6 years after diagnosis. Among survivors, 45.1% reported pain, and 11.5% reported severe pain. Among patients with current pain, 46% reported low overall QOL versus only 12% of those without pain ( P < .001). On multivariable analysis after adjustment for age, sex, and stage of disease, pain was associated with trimodality treatment (odds ratio [OR], 3.55; 95% CI, 1.06-12.77). Multivariable analysis of QOL issues revealed that pain was associated with major depression (OR, 3.91; 95% CI, 1.68-9.11), anxiety (OR, 4.22; 95% CI, 2.28-7.81), poor recreation (OR, 3.31; 95% CI, 1.70-6.48), and low overall QOL (OR, 2.20; 95% CI, 1.12-4.34). CONCLUSIONS: Years after head and neck cancer treatment, pain remains a significant problem and is associated with worse QOL. Future efforts should focus on preventing pain from treatment and comprehensive management.
Entities:
Keywords:
analgesics; chronic pain; head and neck neoplasms; opioids; pain; quality of life; survivorship
Authors: Joaquin E Jimenez; Marci Lee Nilsen; William E Gooding; Jennifer L Anderson; Nayel I Khan; Leila J Mady; Tamara Wasserman-Wincko; Umamaheswar Duvvuri; Seungwon Kim; Robert L Ferris; Mario G Solari; Mark W Kubik; Jonas T Johnson; Shaum Sridharan Journal: Oral Oncol Date: 2021-10-26 Impact factor: 5.337
Authors: Pam Baker DeGuzman; David L Vogel; Bethany Horton; Veronica Bernacchi; C Allen Cupp; B J Ferrebee Ghamandi; Ivora D Hinton; Christi Sheffield; Mark J Jameson Journal: J Cancer Surviv Date: 2021-05-13 Impact factor: 4.062
Authors: Marci Lee Nilsen; David A Clump; Mark Kubik; Karen Losego; Alyssa Mrozek; Elizabeth Pawlowicz; Debra Pickford; Shaum Sridharan; Katie Traylor; Tamara Wasserman-Wincko; Kelly Young; Dan Zandberg; Jonas T Johnson Journal: Head Neck Date: 2020-05-18 Impact factor: 3.147
Authors: Sewit Teckie; Jeffrey Solomon; Karthik Kadapa; Keisy Sanchez; David Orner; Dennis Kraus; Dev P Kamdar; Lucio Pereira; Douglas Frank; Michael Diefenbach Journal: JMIR Form Res Date: 2021-03-19